MedTrace Logo

Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy

NCT01044875 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-01-08

No results posted yet for this study

Summary

The purpose of this study is to measure effectiveness of yellow 577 nm laser compared to conventional green laser 532 nm for diabetic retinopathy in terms of number of treatment sessions required and visual acuity outcome.

The study also compares pain score of patients receiving laser treatment and side effects of laser treatment.

Conditions

  • Proliferative Diabetic Retinopathy

Interventions

PROCEDURE

Pan retinal photocoagulation laser treatment

Eyes with PDR are randomised to treatment with either the green laser 532 nm or 577 nm yellow laser.

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Kenneth C Fong, FRCOphth · University of Malaya Eye Research Centre

  • Nurliza Khaliddin, FRCS · University of Malaya Eye Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-09-30
Completion
2011-10-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01044875 on ClinicalTrials.gov